Skip to main content
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.71
-0.14 (-2.04%)
At close: Apr 28, 2026, 4:00 PM EDT
6.70
-0.01 (-0.15%)
After-hours: Apr 28, 2026, 4:04 PM EDT

Fennec Pharmaceuticals Revenue

In the year 2025, Fennec Pharmaceuticals had annual revenue of $44.64M, down -6.09%. Fennec Pharmaceuticals had revenue of $13.78M in the quarter ending December 31, 2025, with 73.84% growth.

Revenue (ttm)
$44.64M
Revenue Growth
-6.09%
P/S Ratio
5.17
Revenue / Employee
$1,275,486
Employees
35
Market Cap
231.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202544.64M-2.90M-6.09%
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1,284.50%
Dec 31, 20221.54M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Heron Therapeutics 154.90M
Arcturus Therapeutics Holdings 82.03M
Codexis 70.39M
Voyager Therapeutics 40.37M
Orchestra BioMed Holdings 33.48M
Adagene 7.67M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Revenue Rankings

FENC News

More News